Announcements Trials
Browse Landscape

Phase

Phase 1/2 9Phase 1 8Phase 2 4Phase EARLY_PHASE1 2Phase NA 1

Status

Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumor 31Advanced Solid Tumors 12Advanced Solid Tumor 8Solid Tumors 7Mesothelioma 5Retinoblastoma 3Ovarian Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3TCR-T Cells 2Solid Tumor Malignancies 2Metastatic Solid Tumors (Any Localization) 2Mesothelioma, Malignant 2Malignant Solid Tumor 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Tumor 2Unspecified Adult Solid Tumor, Protocol Specific 1Unresectable or Metastatic Advanced Solid Tumors 1Stomach Neoplasms 1Solid Tumor, Adult 1Sleep Apnea, Obstructive 1Sarcoma 1Rhinitis, Allergic, Seasonal 1Rhabdomyosarcoma 1Refractory Solid Tumors 1Recurrence 1Rectal Neoplasms 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1

Interventions

Decitabine 1Antibodies, Bispecific 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Malignant Solid Tumor × Other solid neoplasm × Clear all
NCT04076137 2019-09-03

Targeted T-cell Therapy in Solid Tumors

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Phase EARLY_PHASE1 Unknown
10 enrolled
Other solid neoplasm

Malignant Solid Tumor

NCT01632696 2017-07-11

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Peregrine Pharmaceuticals

Phase EARLY_PHASE1 Terminated
11 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡